All In MedTech

Device Trial Radar · NCT07225933

A Retrospective, Multi-center Real-world Study of Steerable Ureteroscopic Renal Evacuation (SURE) Procedure With the CVAC® System

Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

3,000

Planned (sponsor's estimate)

Start

Feb 1, 2024

Primary completion

Dec 30, 2026

Study completion Jun 2027

Sponsor

Lead sponsor
Calyxo, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
University of California, San Diego; University of Alabama at Birmingham; University of Texas Southwestern Medical Center; OhioHealth Research Institute; Feinstein Institute for Medical Research; U.S. Urology Partners; Western New York Urology Associates; Integrity Clinical Network; University of Kansas Medical Center
First posted
Nov 10, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a retrospective, multi-center collaboration to assess real-world outcomes of a novel steerable aspiration system, the CVAC® System ("CVAC"), and flexible and navigable suction ureteral access sheath (FANS) for the treatment of urinary stones.

Conditions

  • Urolithiasis
  • Kidney Stone
  • Kidney Stones

Interventions

  • CVAC® SYSTEMDevice

    The CVAC Aspiration System is a sterile, single use, steerable ureteral catheter system with integrated vision, irrigation and aspiration for the treatment and removal of urinary stones (kidney stones, fragments, and dust).

  • FLEXIBLE AND NAVIGATIONAL URETERAL ACCESS SHEATH (FANS) IN FLEXIBLE URETEROSCOPY (FURS)Device

    FANS is designed to incorporate suction to facilitate stone fragment removal through its lumen and is used with a separate ureteroscope. FANS is fitted with a Y connector with a pressure control vent and connects to a standard vacuum device. A separate ureteroscope provides direct visualization and irrigation and a separate specimen collector captures stone debris.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Stone free StatusTime frame: Post-Operative up to 90 Days
  2. Intra- & Post-Operative ComplicationsTime frame: Intra- & Post-Operative up to 90 Days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of California San Diego (UCSD)

    La Jolla, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.